ArticleJournal of molecular histology2026
Ceramide-PKCζ signaling axis mediates burn-enhanced ectopic calcification during Achilles tendon healing.
Article in Journal of molecular histology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Burn injury frequently leads to heterotopic ossification (HO) during tendon healing, but the underlying molecular mechanisms remain poorly understood. This study investigated the role of the ceramide-protein kinase C zeta (PKCζ) signaling axis in burn-enhanced ectopic calcification during Achilles tendon healing and evaluated the therapeutic potential of PKCζ inhibition. A combined burn injury and Achilles tendon puncture model was established in C57BL/6 mice, with sham control, tendon puncture, and burn combined tendon puncture groups. Micro-computed tomography analysis revealed significantly increased bone volume at the calcaneal insertion site in burn-injured animals. Both total PKCζ and phosphorylated PKCζ expression were markedly elevated in the burn combined injury group. In vitro, C2-ceramide treatment significantly enhanced PKCζ activation and promoted osteogenic differentiation of Achilles tendon stem cells, as evidenced by increased alkaline phosphatase activity, calcium deposition, and upregulation of runt-related transcription factor 2 and osteopontin expression. Co-treatment with 2-acetyl-1,3-cyclopentanedione (ACPD), an atypical PKC (aPKC) inhibitor, effectively blocked ceramide-induced PKCζ activation and osteogenic differentiation. In vivo administration of the aPKC inhibitor significantly reduced ectopic calcification (bone volume on micro-CT) and decreased expression of PKCζ and osteogenic markers. These findings suggest that burn injury enhances ectopic calcification during Achilles tendon healing through activation of the ceramide-PKCζ signaling pathway, promoting aberrant osteogenic differentiation of tendon stem cells. Atypical PKC inhibition represents a potential therapeutic strategy for preventing burn-associated ectopic calcification.
Indexed as
Identifiers
42371194What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.